Gene · 55801
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug. | Int J Mol Sci | 2023 | 37762393 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
| Interaction of S100A6 Protein with the Four-Helical Cytokines. | Biomolecules | 2023 | 37759746 | PubTator, text mining | PubMed |
| Investigation of the anti-inflammatory effects of native potential probiotics as supplementary therapeutic agents in an in-vitro model of inflammation. | BMC Complement Med Ther | 2023 | 37735396 | PubTator, text mining | PubMed |
| The interleukin-10 family: Major regulators of the immune response against Plasmodium falciparum infections. | Saudi J Biol Sci | 2023 | 37727525 | PubTator, text mining | PubMed |
| Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors. | Cancer Med | 2023 | 37712645 | PubTator, text mining | PubMed |
| Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. | J Transl Med | 2023 | 37697300 | PubTator, text mining | PubMed |
| CD4+ T-cell subsets in autoimmune hepatitis: A review. | Hepatol Commun | 2023 | 37695088 | PubTator, text mining | PubMed |
| Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation. | Saudi J Biol Sci | 2023 | 37675062 | PubTator, text mining | PubMed |
| Desulfurization of Diesel Using Ionic Liquids: Process Design and Optimization Using COSMO-Based Models and Aspen Plus. | ACS Omega | 2023 | 37636952 | PubTator, text mining | PubMed |
| Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. | Pharmaceuticals (Basel) | 2023 | 37630981 | PubTator, text mining | PubMed |
| The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia. | J Exp Clin Cancer Res | 2023 | 37620852 | PubTator, text mining | PubMed |
| Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis. | Front Immunol | 2023 | 37600781 | PubTator, text mining | PubMed |
| Reduced DEFA5 Expression and STAT3 Activation Underlie the Submucosal Invasion of Early Gastric Cancers. | Digestion | 2023 | 37598668 | PubTator, text mining | PubMed |
| Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study. | Pharmacol Rep | 2023 | 37587394 | PubTator, text mining | PubMed |
| Application of single-cell omics in inflammatory bowel disease. | World J Gastroenterol | 2023 | 37576705 | PubTator, text mining | PubMed |
| Targeting Epithelium Dysfunction and Impaired Nasal Biofilms to Treat Immunological, Functional, and Structural Abnormalities of Chronic Rhinosinusitis. | Int J Mol Sci | 2023 | 37569753 | PubTator, text mining | PubMed |
| HIV-1-Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities. | Int J Mol Sci | 2023 | 37569570 | PubTator, text mining | PubMed |
| A half-century of research on tuberculosis: Successes and challenges. | J Exp Med | 2023 | 37552470 | PubTator, text mining | PubMed |
| Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art. | Cancer Cell Int | 2023 | 37543612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55801/papers?page=8